Literature DB >> 10980606

Bax and Bcl-xL independently regulate apoptotic changes of yeast mitochondria that require VDAC but not adenine nucleotide translocator.

S Shimizu1, Y Shinohara, Y Tsujimoto.   

Abstract

Mitochondria play an essential role in apoptosis by releasing apoptogenic molecules such as cytochrome c and AIF, and some caspases, which are all regulated by Bcl-2 family proteins. Pro-apoptotic Bax and Bak have been shown to induce cytochrome c release and loss of membrane potential (Deltapsi) leading to AIF release in the isolated mitochondria. We have previously shown that Bax and Bak open the voltage-dependent anion channel (VDAC) allowing cytochrome c to pass through the channel, and Bcl-xL closes the channel. However, it has been reported that it is adenine nucleotide translocator (ANT) with which Bax/Bcl-xL interacts that modulate the channel activity. Here, we investigated the role of ANT and VDAC in the changes of isolated mitochondria triggered by Bax and by chemicals that induce permeability transition (PT). In rat and yeast mitochondria, Bax did not affect the ADP/ATP exchange activity of ANT. VDAC-deficient but not ANT-deficient yeast mitochondria showed resistance to cytochrome c release, Deltapsi loss, and swelling caused by Bax and PT inducers. Bcl-xL showed similar inhibition of all these changes in ANT-deficient and wild type yeast mitochondria. Furthermore, Bax induces cytochrome c release in wild type yeast cells but not VDAC1-deficient yeast cells. These data indicate that VDAC, but not ANT, is essential for apoptotic mitochondrial changes. The data also indicate that Bcl-xL and Bax possess an ability to regulate mitochondrial membrane permeability independently of other Bcl-2 family members.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10980606     DOI: 10.1038/sj.onc.1203788

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  44 in total

1.  Directed evolution of mammalian anti-apoptosis proteins by somatic hypermutation.

Authors:  Brian S Majors; Gisela G Chiang; Nels E Pederson; Michael J Betenbaugh
Journal:  Protein Eng Des Sel       Date:  2011-12-09       Impact factor: 1.650

2.  Response of yeast to the regulated expression of proteins in the Bcl-2 family.

Authors:  Peter Polcic; Michael Forte
Journal:  Biochem J       Date:  2003-09-01       Impact factor: 3.857

Review 3.  The role of VDAC in cell death: friend or foe?

Authors:  Kyle S McCommis; Christopher P Baines
Journal:  Biochim Biophys Acta       Date:  2011-10-28

4.  On the role of VDAC in apoptosis: fact and fiction.

Authors:  Tatiana K Rostovtseva; Wenzhi Tan; Marco Colombini
Journal:  J Bioenerg Biomembr       Date:  2005-06       Impact factor: 2.945

5.  Activation of Bak in ultrasound-induced, JNK- and p38-independent apoptosis and its inhibition by Bcl-2.

Authors:  Manabu Kinoshita; Yutaka Eguchi; Kullervo Hynynen
Journal:  Biochem Biophys Res Commun       Date:  2006-12-18       Impact factor: 3.575

6.  NMR structural investigation of the mitochondrial outer membrane protein VDAC and its interaction with antiapoptotic Bcl-xL.

Authors:  Thomas J Malia; Gerhard Wagner
Journal:  Biochemistry       Date:  2007-01-16       Impact factor: 3.162

Review 7.  Reflections on VDAC as a voltage-gated channel and a mitochondrial regulator.

Authors:  Carmen A Mannella; Kathleen W Kinnally
Journal:  J Bioenerg Biomembr       Date:  2008-06       Impact factor: 2.945

Review 8.  Uncovering the role of VDAC in the regulation of cell life and death.

Authors:  Varda Shoshan-Barmatz; Nurit Keinan; Hilal Zaid
Journal:  J Bioenerg Biomembr       Date:  2008-06       Impact factor: 2.945

Review 9.  Pharmacological modulation of mitochondrial ion channels.

Authors:  Luigi Leanza; Vanessa Checchetto; Lucia Biasutto; Andrea Rossa; Roberto Costa; Magdalena Bachmann; Mario Zoratti; Ildiko Szabo
Journal:  Br J Pharmacol       Date:  2019-01-02       Impact factor: 8.739

Review 10.  VDAC activation by the 18 kDa translocator protein (TSPO), implications for apoptosis.

Authors:  Leo Veenman; Yulia Shandalov; Moshe Gavish
Journal:  J Bioenerg Biomembr       Date:  2008-06       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.